A breakthrough Kiwi-made cancer therapy has moved closer to market, with its developers entering a multimillion-dollar deal with a global drug giant.
The clever biotech at the heart of the deal between Wellington Zhaotai Therapiesand India-based pharma company Dr Reddy’s Laboratories is now undergoing a first-of-its-kind medical trial in New Zealand, targeted at certain types of lymphoma.